SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-15-000030
Filing Date
2015-05-06
Accepted
2015-05-06 16:03:21
Documents
13
Period of Report
2015-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20150506x8xkdoc.htm 8-K 32626
2 PRESS RELEASE pdli-20150506x8xkex991.htm EX-99.1 102456
3 PRESENTATION pdli-20150506x8xkex992.htm EX-99.2 3925
4 INFORMATION SHEET pdli-20150506x8xkex993.htm EX-99.3 521351
5 pdllogo75a01a02a01.jpg GRAPHIC 5218
6 slide1q12015.jpg GRAPHIC 128345
7 slide2q12015.jpg GRAPHIC 221518
8 slide3q12015.jpg GRAPHIC 110572
9 slide4q12015.jpg GRAPHIC 128849
10 slide5q12015a.jpg GRAPHIC 123522
11 slide6q12015.jpg GRAPHIC 141002
12 slide7q12015.jpg GRAPHIC 137195
13 slide8q12015.jpg GRAPHIC 116087
  Complete submission text file 0000882104-15-000030.txt   2195292
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 15836908
SIC: 2836 Biological Products, (No Diagnostic Substances)